Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Mazindol

EU orphan designation number: EU/3/15/1547   
Active ingredient: Mazindol
Indication: Treatment of narcolepsy
Sponsor: NeuroLifeSciences
1 rue de Stockholm, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/10/2015 Orphan designation EMA/OD/002/15 (2015)7018 of 9/10/2015